Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Managed_access_program> ?p ?o. }
Showing items 1 to 30 of
30
with 100 items per page.
- Managed_access_program abstract "Managed Access Program (MAP) is an umbrella term used when defining an ethical solutions-based approach to provision of unapproved medicines for patients with unmet medical needs, typical of the following scenarios when drugs: Are still in clinical development and have yet to be approved May never be approved , but still have medicinal value for a very small population Are approved in one country, but not in another Have been discontinued in a particular market Are an alternative to a drug discontinued globally Are approved but not yet commercialized Are used off-label in some countriesA variety of terms are used to describe these programs including: Expanded Access Early Access Compassionate Use Named Patient Pre-Approval Access Unlicensed Off-LabelThese regulatory programs are put in place on a country-by-country basis and can vary significantly across markets.".
- Managed_access_program wikiPageExternalLink 7398632.stm.
- Managed_access_program wikiPageExternalLink 453242?ref=25.
- Managed_access_program wikiPageExternalLink making-early-access-real:-getting-treatments-to-patients-with-no-other-option-winter-10.html.
- Managed_access_program wikiPageExternalLink 3164.
- Managed_access_program wikiPageExternalLink 3488-managing-access-to-drugs-prior-to-approval-and-launch?list=n.
- Managed_access_program wikiPageExternalLink OnePage.
- Managed_access_program wikiPageExternalLink 17untested.html?_r=4&ref=policy.
- Managed_access_program wikiPageID "35006500".
- Managed_access_program wikiPageRevisionID "592350544".
- Managed_access_program hasPhotoCollection Managed_access_program.
- Managed_access_program subject Category:Medical_treatments.
- Managed_access_program type Abstraction100002137.
- Managed_access_program type Act100030358.
- Managed_access_program type Activity100407535.
- Managed_access_program type Care100654885.
- Managed_access_program type Event100029378.
- Managed_access_program type MedicalTreatments.
- Managed_access_program type PsychologicalFeature100023100.
- Managed_access_program type Treatment100658082.
- Managed_access_program type Work100575741.
- Managed_access_program type YagoPermanentlyLocatedEntity.
- Managed_access_program comment "Managed Access Program (MAP) is an umbrella term used when defining an ethical solutions-based approach to provision of unapproved medicines for patients with unmet medical needs, typical of the following scenarios when drugs: Are still in clinical development and have yet to be approved May never be approved , but still have medicinal value for a very small population Are approved in one country, but not in another Have been discontinued in a particular market Are an alternative to a drug discontinued globally Are approved but not yet commercialized Are used off-label in some countriesA variety of terms are used to describe these programs including: Expanded Access Early Access Compassionate Use Named Patient Pre-Approval Access Unlicensed Off-LabelThese regulatory programs are put in place on a country-by-country basis and can vary significantly across markets.".
- Managed_access_program label "Managed access program".
- Managed_access_program sameAs m.0j63jp_.
- Managed_access_program sameAs Q6746639.
- Managed_access_program sameAs Q6746639.
- Managed_access_program sameAs Managed_access_program.
- Managed_access_program wasDerivedFrom Managed_access_program?oldid=592350544.
- Managed_access_program isPrimaryTopicOf Managed_access_program.